EMEA-001969-PIP01-16
Key facts
| Active substance |
Allogeneic human neural stem cells genetically modified to express c-MycERTAM, a c-Myc and modified oestrogen receptor fusion protein (CTX0E03)
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0246/2016
|
| PIP number |
EMEA-001969-PIP01-16
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
Treatment of cerebral infarction
|
| Route(s) of administration |
Intracerebral use
|
| Contact for public enquiries |
ReNeuron Ltd
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|